YMAB logo

Y-mAbs Therapeutics (YMAB) EBITDA

Annual EBITDA

-$30.67 M
-$5.73 M-22.97%

December 31, 2024


Summary


Performance

YMAB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherYMABprofitabilitymetrics:

Quarterly EBITDA

-$5.83 M
+$2.61 M+30.93%

December 31, 2024


Summary


Performance

YMAB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherYMABprofitabilitymetrics:

TTM EBITDA

-$30.67 M
-$2.80 M-10.03%

December 31, 2024


Summary


Performance

YMAB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherYMABprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

YMAB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-23.0%0.0%0.0%
3 y3 years+41.8%-532.1%+67.4%
5 y5 years+63.0%-532.1%+67.4%

YMAB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-23.0%+67.4%-532.1%+85.3%-34.4%+76.6%
5 y5-year-23.0%+74.3%-117.2%+85.5%-34.4%+76.6%
alltimeall time-80.0%+74.3%-117.2%+85.5%-698.2%+76.6%

Y-mAbs Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$30.67 M(+23.0%)
-$5.83 M(-30.9%)
-$30.67 M(+10.0%)
Sep 2024
-
-$8.45 M(-12.3%)
-$27.87 M(+3.2%)
Jun 2024
-
-$9.64 M(+42.8%)
-$27.00 M(+10.8%)
Mar 2024
-
-$6.75 M(+122.2%)
-$24.37 M(-2.3%)
Dec 2023
-$24.94 M(-73.5%)
-$3.04 M(-59.9%)
-$24.94 M(+9.3%)
Sep 2023
-
-$7.58 M(+8.3%)
-$22.82 M(-44.4%)
Jun 2023
-
-$7.00 M(-4.4%)
-$41.03 M(-44.4%)
Mar 2023
-
-$7.32 M(+693.0%)
-$73.79 M(-21.5%)
Dec 2022
-$93.97 M(+78.5%)
-$923.00 K(-96.4%)
-$93.97 M(-26.9%)
Sep 2022
-
-$25.79 M(-35.1%)
-$128.51 M(-2.1%)
Jun 2022
-
-$39.76 M(+44.6%)
-$131.28 M(+15.1%)
Mar 2022
-
-$27.50 M(-22.5%)
-$114.02 M(+116.6%)
Dec 2021
-$52.64 M
-$35.47 M(+24.2%)
-$52.64 M(+41.7%)
Sep 2021
-
-$28.56 M(+27.0%)
-$37.15 M(-9.7%)
Jun 2021
-
-$22.50 M(-166.4%)
-$41.14 M(-30.3%)
DateAnnualQuarterlyTTM
Mar 2021
-
$33.88 M(-269.6%)
-$59.00 M(-50.6%)
Dec 2020
-$119.54 M(+44.3%)
-$19.98 M(-38.6%)
-$119.54 M(-3.0%)
Sep 2020
-
-$32.55 M(-19.3%)
-$123.24 M(+7.2%)
Jun 2020
-
-$40.35 M(+51.4%)
-$115.00 M(+23.3%)
Mar 2020
-
-$26.66 M(+12.6%)
-$93.27 M(+12.6%)
Dec 2019
-$82.84 M(+91.8%)
-$23.68 M(-2.6%)
-$82.84 M(+13.1%)
Sep 2019
-
-$24.31 M(+30.6%)
-$73.22 M(+21.4%)
Jun 2019
-
-$18.61 M(+14.7%)
-$60.32 M(+16.1%)
Mar 2019
-
-$16.23 M(+15.4%)
-$51.96 M(+20.3%)
Dec 2018
-$43.20 M(+124.5%)
-$14.06 M(+23.3%)
-$43.20 M(+12.5%)
Sep 2018
-
-$11.41 M(+11.3%)
-$38.41 M(+24.5%)
Jun 2018
-
-$10.25 M(+37.1%)
-$30.85 M(+49.8%)
Mar 2018
-
-$7.48 M(-19.4%)
-$20.60 M(+57.0%)
Dec 2017
-$19.24 M(+12.9%)
-$9.28 M(+141.4%)
-$13.12 M(+241.4%)
Sep 2017
-
-$3.84 M
-$3.84 M
Dec 2016
-$17.04 M
-
-

FAQ

  • What is Y-mAbs Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Y-mAbs Therapeutics?
  • What is Y-mAbs Therapeutics annual EBITDA year-on-year change?
  • What is Y-mAbs Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Y-mAbs Therapeutics?
  • What is Y-mAbs Therapeutics quarterly EBITDA year-on-year change?
  • What is Y-mAbs Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Y-mAbs Therapeutics?
  • What is Y-mAbs Therapeutics TTM EBITDA year-on-year change?

What is Y-mAbs Therapeutics annual EBITDA?

The current annual EBITDA of YMAB is -$30.67 M

What is the all time high annual EBITDA for Y-mAbs Therapeutics?

Y-mAbs Therapeutics all-time high annual EBITDA is -$17.04 M

What is Y-mAbs Therapeutics annual EBITDA year-on-year change?

Over the past year, YMAB annual EBITDA has changed by -$5.73 M (-22.97%)

What is Y-mAbs Therapeutics quarterly EBITDA?

The current quarterly EBITDA of YMAB is -$5.83 M

What is the all time high quarterly EBITDA for Y-mAbs Therapeutics?

Y-mAbs Therapeutics all-time high quarterly EBITDA is $33.88 M

What is Y-mAbs Therapeutics quarterly EBITDA year-on-year change?

Over the past year, YMAB quarterly EBITDA has changed by $0.00 (0.00%)

What is Y-mAbs Therapeutics TTM EBITDA?

The current TTM EBITDA of YMAB is -$30.67 M

What is the all time high TTM EBITDA for Y-mAbs Therapeutics?

Y-mAbs Therapeutics all-time high TTM EBITDA is -$3.84 M

What is Y-mAbs Therapeutics TTM EBITDA year-on-year change?

Over the past year, YMAB TTM EBITDA has changed by $0.00 (0.00%)